Independent risk factors affecting death-censored graft survival
| Variable | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | ||
| Donor age | 1.060 (0.998–1.125) | 0.060 | 1.089 (0.997–1.189) | 0.058 | |
| Donor sex (female) | 0.028 (0.297–3.554) | 0.966 | |||
| Deceased donor | 0.955 (0.200–4.568) | 0.954 | |||
| Recipient age | 0.987 (0.940–1.036) | 0.596 | |||
| Recipient medical history | |||||
| Diabetes | 3.347 (0.955–11.736) | 0.059 | |||
| Hypertension | 0.278 (0.080–0.970) | 0.045 | 0.248 (0.05–1.122) | 0.070 | |
| Recipient sex (female) | 0.521 (0.134–2.026) | 0.347 | |||
| Dialysis | 0.978 | ||||
| Hemodialysis | 1.101 (0.275–4.410) | 0.891 | |||
| Peritoneal dialysis | 0.899 (0.093–8.670) | 0.927 | |||
| Duration of dialysis | 0.999 (0.983–1.015) | 0.912 | |||
| Graft weight | 1.013 (1.006–1.020) | <0.001 | |||
| Gw/Rw ratio | 1.551 (1.140–2.109) | 0.005 | 1.603 (1.125–2.285) | 0.009 | |
| No. of graft artery | 0.929 (0.311–2.777) | 0.894 | |||
| No. of graft vein | 2.220 (0.393–12.554) | 0.367 | |||
| ABO incompatibility | 2.474 (0.495–12.363) | 0.270 | |||
| HLA mismatch | 0.936 (0.647–1.354) | 0.726 | |||
| Delayed graft function | 6.458 (1.334–31.262) | 0.020 | |||
| Postoperative complication | |||||
| Surgical | 1.141 (0.842–1.546) | 0.396 | |||
| Urological | 0.047 (0.000–530897.684) | 0.713 | |||
| Infectious | 5.936 (1.222–28.813) | 0.027 | |||
| Bacterial infection | 1.046 (0.268–4.076) | 0.948 | |||
| Viral infection | 0.883 (0.183–4.261) | 0.877 | |||
| Rejection | 9.920 (2.781–35.389) | <0.001 | 10.135 (2.031–50.578) | 0.005 | |
| Malignancy | 0.048 (0.000–24138133.42) | 0.766 | |||
Gw, graft weight; Rw, recipient weight; HLA, human leukocyte antigen.